Shaddock makes sense of intersubjectivity, the functional paradigm shift in highbrow psychotherapy, as both a way of thinking about our psychological lives and a way of doing clinical work. Applying it to relational systems means investigating the experience of each partner/ member from inside his/her perspective and without judgment.The book illustrates how that approach lowers defenses and lets in insights, mutual understanding, and renewed hope; it demonstrates that treatment built on empathic awareness of contexts and connections can actually also lead to individual transformation.

Apart from Alzheimer's dementia, depressive disorders are emerging to account for the next greatest share of disability among older adults. Depressive illnesses complicate the recovery of many important medical illnesses and are associated with suicide death in the elderly at rates exceeding those seen in young adults. This issue of Psychiatric Clinics provides information for general adult psychiatrists, internal medicine geriatricians, and primary care physicians and care extenders to enable them to meet the most basic needs of depressed older adults. Topics in this issue address the questions: What is late life depression? What are the unique cognitive deficits seen in late life depression? What is the nature of the two-way relationship between medical illness and depression in late life depression? What complications arise from late life depression? What is the relationship between late life depression and dementing illnesses? What assessments should be done of the person with suspected late life depression? What are the psychological treatments for late life depression? What is the role of medications in late life depression? What is the role of alternative treatments in late life depression? Is there a role for ECT/TMS/VNS in late life depression? Vaughn McCall of Georgia Health Sciences University provides his expertise to lead this issue.

The "spectrum? in this disorder is Autistic Disorder, Asperger Syndrome, and Pervasive Developmental Disorder. This issue specifically addresses acute management of the extreme behaviors that accompany this disorder spectrum: extreme behaviors, complete lack of communication, inability to learn or express language, etc, and covers in-hospital or residential therapies as well as in-home family involvement. Medical treatment for this disorder is the main focus of discussion in topics such as: Emotional Regulation: Concepts and Practice in ASD; Specialized Inpatient Treatment of ASD; Residential Treatment of Severe Behavioral Disturbance in ASD; Treatment of ASD in General Child Psychiatry Units; Behavioral Approaches to Acute Problems; Communication Strategies for Behavioral Challenges in ASD, along with topics covering Psychiatric Assessment of Acute Presentations in ASD; Sensory Regulation and its Relationship to Acute Problems in ASD; Family Dysfunction, Assessment and Treatment in the context of Severe Behavioral Disturbance in ASD; and Self Injurious Behavior in ASD.

It is widely recognized that neuropsychiatric disturbances contribute substantially to disability among persons with traumatic brain injury (TBI). This issue of Psychiatric Clinics addresses the most common and the most clinically challenging neuropsychiatric sequelae of TBI. The overarching aim of this publication is to provide clinicians with information about the clinical characteristics, diagnostic assessment, neurobiology and treatment of these conditions that will be useful in their work with individuals and families affected by TBI. Topics include: Posttraumatic Encephalopathy; Cognitive Disorders after TBI; Emotional and Behavioral Dyscontrol after TBI; Mood Disorders following TBI; Apathy following TBI; Psychotic Disorders following TBI; Sleep and Fatigue following TBI; TBI and Posttraumatic Stress Disorder; Neuropsychiatry of Persistent Post-concussive Symptoms; Psychiatric Disorders following Pediatric TBI.

Because of the complex range of factors to be considered in pscyhosis -genetic, neurologic, biologic, environmental, family, culture - this issue of Child and Adolescent Psychiatric Clinics presents aspects that have the greatest relevance and impact in diagnosing and treating child and adolescent patients. Among some of the topics covered: Schizophrenia, Affective disorders and Psychosis, Comorbid diseases, Neurocognition, Genetics, Neuroimaging findings, and Treatment approaches of Psychopharmacology, Psychotherapy, and Community Rehabilitation. Jean Frazier, an expert in child and adolescent neuropsychiatry and in child psychopharmacology, leads this issue along with Yael Dvir, whose research and clinical interests include childhood psychosis and the associations between childhood psychosis and Autistic Spectrum Disorders.

This volume concentrates on teaching group dynamics with an experiential, process focus. The procedure for instruction seeks to provide an integration of cognitive and affective components in learning how to tune into, and effectively use, group dynamics. Instructors and supervisors are provided with specific techniques for helping students understand manifestations of resistance, countertransference issues, assuming a process orientation, and dealing with both individual and group-as-a-whole concerns. Immensely practical and classroom tested.

Chapter 1 provides an overview and a discussion of ethical principles in group work. Chapter 2 focuses on how to structure the class, including a systematic method for monitoring group sessions, providing feedback to students, and addressing specific ethical concerns such as confidentiality and involuntary group membership. Chapter 3 develops the importance, and a process for, helping students to stay present-centered, keeping the group in a here-and-now focus, and how to recognize process. Chapter 4 presents the barriers to self-awareness and group process. Chapter 5 addresses how developing trust and cohesion in groups leads to therapeutic work on significant issues for group members. Chapter 6 describes the link between what is taking place in the present-centered group session and the past. Chapter 7 focuses on the roles that group members assume and the impact these roles may have on the progress and functioning of the group. Chapter 8 deals with teaching students to recognize and deal with overt and covert conflict in the group. Chapter 9 provides an introduction to the use of expressive techniques in groups. Chapter 10 presents specific exercises that are useful in teaching concepts, ranging from get-acquainted exercises to more complex ones for uncovering the self.

Alessandra Lemma - Winner of the Levy-Goldfarb Award for Child Psychoanalysis! Relating to Self-Harm and Suicide presents original studies and research from contemporary psychoanalysts, therapists and academics focusing on the psychoanalytic understanding of suicide and self-harm, and how this can be applied to clinical work and policy. This powerful critique of current thinking suggests that suicide and self-harm must be understood as having meaning within interpersonal and intrapsychic relationships, offering a new and more hopeful dimension for prevention and recovery. Divided into three sections, the book includes: a theoretical overview examples of psychoanalytic practice with self-harming and suicidal patients applications of psychoanalytic thinking to suicide and self-harm prevention. Relating to Self-Harm and Suicide will be helpful to psychoanalytic therapists, analysts and mental health professionals wanting to integrate psychoanalytic ideas into their work with self-harmers and the suicidal. This text will also be of use to academics and professionals involved in suicidal prevention.

Kiesler's "Beyond the Disease Model of Mental Disorder" goes beyond recent volumes which argue that psychotropic medications are being overused and abused in contemporary mental health settings. Elliott Valenstein, for example, an emeritus professor of psychology and neuroscience at the University of Michigan, recently argues that people should be highly suspicious of the claim that all mental illness is primarily a biochemical disorder. In his 1998 book, "Blaming the Brain: The Truth about Drugs and Mental Health," Valenstein does not argue that drugs never work or that patients should discontinue taking medication. Valenstein's central point, instead, is that drugs do not attack the real cause of a disorder, since biochemical theories are an unproven hypothesis and probably a false one.

Inasmuch as Kiesler's volume is concerned exclusively with scientific explanations of mental disorders, it does not review at all the evidence for psychotropic medications or for other treatments of mental disorders. Kiesler does highlight a message similar to that of Valenstein, who rejects the hypothesis that mental illness is primarily a biochemical disorder. After a comprehensive review of the relevant scientific evidence, Kiesler concludes that henceforth the study of mental disorders must be guided by multicausal theories and research that systematically include an array of biological, psychological, and sociocultural causal factors. Kiesler adds that, in order for this to be accomplished, the mental health field and the public at large must first abandon the invalid monocausal biomedical (disease) model of mental disorder.

Patients in psychiatry, or their parents, experiment with alternative methods and practices; psychiatrists, in search of scientifically-based discussion and evidence of use for daily practice, find that information in this issue of Child and Adolescent Psychiatric Clinics. Readers will find clinically focused information in the major categories of Selected Treatments, Selected Disorders, and Perspectives on Clinical Complementary and Alternative Therapies. Pharmacologic and non-pharmacologic treatments are discussed for ADHD, Mood disorders, Autism, Learning and Cognitive disorders, and Neurologic disturbances, such as sleep, traumatic brain injury, headache, etc. EEG and Neurofeedback, Meditation and Movement Therapies, Music Therapy, Massage, Acupuncture, and other body-based therapies are presented. Evidence for minerals, vitamins, and herbs is discussed, and Ethical and Legal issues for the Psychiatrist are presented. Guest Editors Deborah Simkin and Charles Popper, with decades of experience in working with complementary therapies, lead this issue.

Emerging approaches to treating addictions and minimizing relapse are spotlighted in this idea-packed volume, as alternatives or adjuncts to standard psychological and pharmacological therapies. Its biopsychosocial perspective delves into the causes and processes of chemical dependence, and the clinical characteristics it shares with other addictions (e.g., food, sex, gambling, online activities), to identify client needs that substance abuse may fulfill. Accordingly, the diverse modalities featured here address substance addiction on multiple levels, offering clients physical or mental stimulation and/or emotional relief as well as affording different degrees of autonomy. Methods can be mixed and matched to reinforce treatment goals, and clinicians can tailor treatment to individual issues and interests to assure clients nuanced and meaningful care. Included in the coverage: * Use of herbal medicine to treat drug addiction. * EMDR therapy and the treatment of substance abuse and addiction. * Evaluating the change processes in drug users' interventions. * Web-based interventions for substance abuse. * Physical exercise and treatment of addiction. * Mindfulness to reduce the anxiety during the abstinence * Neurofeedback to deal with craving and anxiety symptoms Psychologists, psychiatrists, clinical social workers, and addiction counselors and educators will find Innovations in the Treatment of Substance Addiction a valuable sourcebook for understanding addiction-and intervention-in its wider context.

Disasters! Looking beyond their acute impact to how they affect communities in the years that follow is the focus of discussion in this issue of Psychiatric Clinics. Reviews of cases of well known disasters such as 9/11, the 2004 South Asian tsunami, Hurricane Katrina, the Haiti earthquake of 2010, the 3/11/11 "triple disaster" in Northern Japan, and others are presented from the perspective of local experts who have been asked to take a long view of what they learned and may still be learning from their post-disaster experiences that mental health professionals faced with future disasters should know. World renown experts in disaster psychiatry and global psychiatry, Craig Katz and Anand Pandya, lead this publication.

Emphasizing diagnosis, causality, and holistic treatment, this is the only book offering a full discussion of Avoidant Personality Disorder for therapists and sufferers. Avoidant Personality Disorder (AvPD) is an extremely widespread, devastating disorder that generally goes unrecognized or misrepresented by what little scientific literature there is on the topic. Therapists are left mystified about how to diagnose and treat it, and patients and other sufferers are at a loss as to what is wrong and how to go about correcting it. The Essential Guide to Overcoming Avoidant Personality Disorder is the only book available to guide both patients and those trying to help them. This thorough and much-needed volume explores the development of AvPD and presents a holistic view of its causes from the psychoanalytic, cognitive-behavioral, and interpersonal perspectives. It offers an extensive section on diagnostic criteria that will be useful to sufferers and therapists, and it discusses the various therapies for AvPD. Finally, and perhaps most critically, the book provides a section intended as a guide for psychiatrists—and a self-help guide for sufferers—including a day-by-day, one-step-at-a-time, monthly guide on how to overcome AvPD.

Psychodynamic Psychotherapy in Child and Adolescent Psychiatric Clinics covers topics in three major categories in two volumes of this series: 1. Approaches to Specific Conditions; 2. Special Features in Working with Children; 3. Research Presented for the Clinician. Specific conditions covered are: Anxiety, Trauma, Depression, Eating Disorders, Incipient Borderline Personality Disorders, and the Medically Ill Youth. Special Features include the various therapies in Psychodynamic psychotherapy: Play Techniques, Use of Boardgames, Perspectives on Psychotropic Medications for Children, Parent Work, Family Therapy, and Dyadic Therapies. Research for Clinicians includes Neuroscience, Evidence Base, and Developmental Perspectives.

Leading researchers are specially invited to provide a complete understanding of a key topic within the multidisciplinary fields of physiology, biochemistry and pharmacology. In a form immediately useful to scientists, this periodical aims to filter, highlight and review the latest developments in these rapidly advancing fields.

The goal for this volume is to provide an up-to-date review of the discriminative stimulus properties of major psychoactive drug classes with an emphasis on how this paradigm enhances our understanding of these drugs and how these findings translate from animals to humans. The drug discrimination paradigm applies to both drugs of abuse and drugs for treating mental illnesses, and research from these studies has provided immense translational value for learning about the mechanisms responsible for drug effects in humans.

Personality disorders, depression, mania, psychosis, behavioral problems, anxiety disorder, attention deficit disorder, dementia, hyperactivity, insomnia, panic disorder, suicide, ? sleep disorder, all the purview of psychiatrity, can be the result of neurotoxicity from chemicals capable of damaging the brain or nervous system. The ambiguity of such outcomes is acknowledged, at the same time emphasizing the value in considering the effects of chemicals on the brain. In this issue of Psychiatric Clinics, some of the topics related to neurotoxicity outcomes are: Review of Cognitive Assessment in Neurotoxicology; Neurologic Manifestations of Chronic Methamphetamine Abuse; Emerging Toxic Neuropathies and Myopathies; Neurotoxic Emergencies; Antidepressant Overdose-induced Seizures; and Neurotoxic Pesticides and Neurologic Effects

In keeping with the growing emphasis on psychiatry in the medical school curriculum, problem-based learning (PBL) offers students a unique patient-centred, multidisciplinary approach to study and the synthesis of knowledge. The new 2nd edition of Problem-Based Behavioral Science and Psychiatry integrates DSM-5 updates and diagnostic criteria, and is fully consistent with PBL models and methods. Building on the strengths of the popular and widely downloaded 1st edition, the 2nd edition is a clinically robust resource for both the medical and the behavioral science student. Over 40 contributors, many themselves graduates of PBL medical schools, apply problem-based learning methods to specific psychiatric disorders, general clinical issues, and bedrock physician skills such as the intake interview and treatment planning. The book's fictional case vignettes illustrated typical patient scenarios, providing real-world context for content areas, and accompanying case diagrams show the relationships between patient behaviour and underlying neurobiological structures. Each student-friendly section ends with helpful review questions. A sampling of the content areas covered: * Childhood development and brain development. * Major psychiatric illnesses, including personality, mood, anxiety, and psychotic disorders. * Stress, substance abuse, and violence. * Eating, sleep, and sexual disorders. * Coping skills and treatment compliance. * End-of-life care. * PLUS chapters on cultural sensitivity, ethical concerns, and the physician/patient relationship. This book is ideal for first and second year medical students wanting to learn about psychiatry in the exciting context of realistic cases. It also makes an excellent prep/review text for third- and fourth-year medical students preparing for the USMLE Step 1 and 2 exams, as well as being suited to graduate students in psychology or clinical social work. Problem-Based Behavioral Science and Psychiatry encourages lifelong learning and helps build the foundation for a lifelong career.

"Translational Neuroimaging: Tools for CNS Drug Discovery, Development and Treatment" combines the experience of academic, clinical and industrial neuroimagers in a unique collaborative approach to provide an integrated perspective of the use of small animal and human brain imaging in developing and validating translational models and biomarkers for the study and treatment of neuropsychiatric disorders. "Translational Neuroimaging: Tools for CNS Drug Discovery, Development and Treatment" examines the translational role of neuroimaging in model development from preclinical animal models, to human experimental medicine, and finally to clinical studies. The focus of this book is to identify and provide common endpoints between species that can serve to inform both the clinic and the bench with the information needed to accelerate clinically-effective CNS drug discovery. This book covers methodical issues in human and animal neuroimaging translational research as well as detailed applied examples of the use of neuroimaging in neuropsychiatric disorders and the development of drugs for their treatment. Offering an accompanying website with illustrations and text available for further knowledge and presentations, "Translational Neuroimaging: Tools for CNS Drug Discovery, Development and Treatment" appeals to non-clinical and clinical neuroscientists working in and studying neuropsychiatric disorders and their treatment as well as providing the novice researcher or researcher outside of his/her expertise the opportunity to understand the background of translational research and the use of imaging in this field.
Provides a background to translational research and the use of brain imaging in neuropsychiatric disordersCritical discussion of the potential and limitations of neuroimaging as a translational tool for identifying and validating biomarkersIdentifies cross species neurosystems and common endpoints necessary to help accelerate CNS drug discovery and development for the treatment of neuropsychiatric disordersFeatures an accompanying website with additional images and text

Schizophrenia remains a poorly understood and yet a profoundly serious condition among all the major medical illnesses. A major shift in the past 5 years has been witnessed among psychiatrists with the belief now that diagnosis and intervention early may have a positive influence on the outcome of schizophrenia. This shift has led to searching for key diagnostic clusters to enhance early diagnosis as well as to concerted efforts to find biomarkers of disease and disease progression. To that end, this issue of the Psychiatric Clinics of North America is dedicated to these contemporary issues that promote 'early intervention' in schizophrenia. Distinguished academic clinicians and neuroscientists provide comprehensive overviews of the present state of knowledge on the epidemiology, early clinical characteristics, and diagnostic changes, proposed pathogenesis, neurobiology, and treatment requirements for this disorder. The optimism and excitement for real progress in schizophrenia research treatment is incorporated into this text. The current state of knowledge is substantial, academically credible, and scientifically based. Topics on the subject of early intervention in and diagnosis of schizophrenia include: The Nosology of Schizophrenia: Defining Illness Boundaries Based upon Symptoms; The Neurodevelopmental Hypothesis of Schizophrenia: a Critical Synthesis; Predicting Risk and the Emergence of Schizophrenia; Is Early Intervention for Psychosis Feasible and Effective?; Can Neuroimaging Be Used to Define Phenotypes and Course of Schizophrenia?; Reliable Biomarkers and Predictors of Schizophrenia and Its Treatment; From Study to Practice: Enhancing Clinical Trials Methods Toward 'Real World' Outcomes; Relapse Prevention in Schizophrenia; Antipsychotic Polypharmacy: Every Clinician's 'Dirty Little Secret'; Cognitive Remediation: Retraining the Brain in Schizophrenia; Peers and Peer-led Interventions; Homelessness; and The Emerging Role of Technology and Social Media in Caring for People with Schizophrenia. Each presentation in this publication includes an Overview, Implications for Practice, with Summarizations of Important Clinical and Learning Points.